Corporation
AbCellera Biologics Inc.
- Meetings this Parliament
- 71
- With MPs
- 4
- Since Nov 2021
- 162
- Active registrations
- 1
Most recent reported meeting: Sep 29, 2026.
Lobbying by AbCellera Biologics Inc.: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.
← LobbyingWho they meet
Since the current Parliament opened.
MPs
- Patrick Weiler Liberal 1
- Stephen Fuhr Liberal 1
- Taleeb Noormohamed Liberal 1
- Michael D. Chong Conservative 1
Institutions
- Innovation, Science and Economic Development Canada (ISED)35
- National Defence (DND)15
- Privy Council Office (PCO)6
- House of Commons5
- Prime Minister's Office (PMO)3
- National Research Council (NRC)3
- Finance Canada (FIN)3
- Public Services and Procurement Canada (PSPC)2
Registrations in effect
In-house (corporation) In effect since Jun 9, 2026 Receives government funding
Filed by Carl Hansen, President
Lobbyists
- Andrew Booth · Chief Financial Officer
- Murray McCutcheon · VP Corporate Development
Institutions they may lobby: Employment and Social Development Canada (ESDC), Finance Canada (FIN), Global Affairs Canada (GAC), Health Canada (HC), House of Commons, Innovation, Science and Economic Development Canada (ISED), National Defence (DND), National Research Council (NRC), Natural Resources Canada (NRCan), Prime Minister's Office (PMO), Privy Council Office (PCO), Public Health Agency of Canada (PHAC), Public Services and Procurement Canada (PSPC)
What they're lobbying on (1)Hide details
- Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products.
Registration 945748-366216-21. Look it up in the official Registry
Reported meetings
Spreadsheet-
Reported by Carl Hansen · In-house (corporation)
- Michael D. Chong · Member of Parliament
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Quinn Rinke · Regional Advisor, National Defence (DND)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Eric Werker · Assistant Clerk, Privy Council Office (PCO)
- Kelvin Bunner · Senior Policy Advisor, Privy Council Office (PCO)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Julie Harb · Policy Advisor, Prime Minister's Office (PMO)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Eric Costen · Deputy Secretary to the Cabinet (Operations), Privy Council Office (PCO)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Cindy Termorshuizen · Deputy Minister, Privy Council Office (PCO)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Natasha Kim · Associate Deputy Minister, National Defence (DND)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Michael Sabia · Clerk of the Privy Council and Secretary to the Cabinet, Privy Council Office (PCO)
- Eric Costen · Deputy Secretary to the Cabinet (Operations), Privy Council Office (PCO)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Paul Moen · Chief of Staff, Innovation, Science and Economic Development Canada (ISED)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Paul Moen · Chief of Staff, Innovation, Science and Economic Development Canada (ISED)
- Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Eric Costen · Deputy Secretary to the Cabinet (Operations), Privy Council Office (PCO)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Taleeb Noormohamed · Member of Parliament
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Philip Jennings · Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
- Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
- Stephanie Tanton · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Scott Malcolm · Surgeon General, National Defence (DND)
- Wendy Hepburn · Deputy Director, National Defence (DND)
- Catharine Liu · Senior Policy Advisor, National Defence (DND)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Paul Moen · Chief of Staff, Innovation, Science and Economic Development Canada (ISED)
- Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
- David McFarlane · Director of Policy, Innovation, Science and Economic Development Canada (ISED)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Patrick Weiler · Member of Parliament
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Jean-Francois Courtois · Executive Director, Innovation, Science and Economic Development Canada (ISED)
- Jean-Pierre Mizero · Manager, Innovation, Science and Economic Development Canada (ISED)
- Cynthia Case · Senior Investment Analyst, Innovation, Science and Economic Development Canada (ISED)
- Inga Pusca · Manager, Innovation, Science and Economic Development Canada (ISED)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Wendy Hadwen · Assistant Deputy Minister, National Defence (DND)
- Wendy Hepburn · Deputy Director, National Defence (DND)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Mitch Davies · President, NRC, National Research Council (NRC)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Eric Costen · Deputy Secretary to the Cabinet (Operations), Privy Council Office (PCO)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
-
Reported by Carl Hansen · In-house (corporation)
- Stephanie Tanton · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
- Milenka Mitrovic · Director General, Innovation, Science and Economic Development Canada (ISED)
- Eric Bourbonnais · Director, Innovation, Science and Economic Development Canada (ISED)
Communications regarding funding from various Government funding programs, opportunities to improve government activity (funding, tax incentives, clinical trials infrastructure, etc) to encourage the innovation economy in Canada with a specific focus on biotech, and programs around procurement opportunities for the Government of Canada relating to biotechnology products. Read more
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.